Form 4: Colgate-Palmolive Director Acquires Additional Shares
SEC Form 4 Filing
Director John P. Bilbrey acquired 222 shares of Colgate-Palmolive common stock at $95.61 per share on July 1, 2024, through a deferred compensation plan.
Summary
- On July 1, 2024, John P. Bilbrey, a director of Colgate-Palmolive, acquired 222 shares of common stock at a price of $95.61 per share.
- This acquisition was made through the Deferred Compensation Plan for Non-Employee Directors.
- Following the transaction, Bilbrey directly owns 32,521 shares and indirectly owns 4,719 shares through a trust.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. A director acquiring shares is generally a good sign, but it's part of a compensation plan, so it's not necessarily a strong indicator of exceptional confidence.
Positives
- The director's acquisition of shares may signal confidence in the company's future performance.
Industry Context
Directors' stock acquisitions are often viewed as a positive sign, reflecting their confidence in the company's prospects. Monitoring such transactions provides insights into management's sentiment and alignment with shareholder interests.
Stakeholder Impact
- The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 07/01/2024 | Date of transaction: Acquisition of 222 shares of common stock. |
| 07/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.